Serine Endopeptidases
"Serine Endopeptidases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis.
Descriptor ID |
D012697
|
MeSH Number(s) |
D08.811.277.656.300.760 D08.811.277.656.959.350
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Serine Endopeptidases".
Below are MeSH descriptors whose meaning is more specific than "Serine Endopeptidases".
This graph shows the total number of publications written about "Serine Endopeptidases" by people in this website by year, and whether "Serine Endopeptidases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 | 1996 | 2 | 0 | 2 | 1998 | 0 | 1 | 1 | 2000 | 1 | 0 | 1 | 2001 | 0 | 2 | 2 | 2002 | 0 | 1 | 1 | 2003 | 1 | 2 | 3 | 2004 | 1 | 1 | 2 | 2005 | 2 | 0 | 2 | 2006 | 1 | 2 | 3 | 2007 | 2 | 2 | 4 | 2008 | 0 | 1 | 1 | 2009 | 1 | 1 | 2 | 2010 | 2 | 3 | 5 | 2011 | 2 | 4 | 6 | 2013 | 2 | 3 | 5 | 2014 | 1 | 2 | 3 | 2015 | 1 | 0 | 1 | 2016 | 3 | 0 | 3 | 2017 | 3 | 2 | 5 | 2018 | 2 | 1 | 3 | 2019 | 0 | 1 | 1 | 2020 | 3 | 1 | 4 | 2021 | 1 | 1 | 2 | 2022 | 0 | 4 | 4 | 2023 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Serine Endopeptidases" by people in Profiles.
-
Yang IV. Proprotein Convertase Subtilisin/Kexin Type 6: A Risk Factor for Survival in Pulmonary Fibrosis? Am J Respir Crit Care Med. 2023 06 01; 207(11):1421-1422.
-
Ferreira MS, Thurman TJ, Jones MR, Farelo L, Kumar AV, Mortimer SME, Demboski JR, Mills LS, Alves PC, Melo-Ferreira J, Good JM. The evolution of white-tailed jackrabbit camouflage in response to past and future seasonal climates. Science. 2023 03 24; 379(6638):1238-1242.
-
Parcha V, Irvin MR, Lange LA, Armstrong ND, Pampana A, Meyer M, Judd SE, Arora G, Arora P. Corin Missense Variants, Blood Pressure, and Hypertension in 11?322 Black Individuals: Insights From REGARDS and the Jackson Heart Study. J Am Heart Assoc. 2022 06 21; 11(12):e025582.
-
Raina K, Kant R, Prasad RR, Kandhari K, Tomar M, Mishra N, Kumar R, Fox JT, Sei S, Shoemaker RH, Chen Y, Maroni P, Agarwal C, Agarwal R. Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models. Mol Carcinog. 2022 07; 61(7):717-734.
-
Bai X, Buckle AM, Vladar EK, Janoff EN, Khare R, Ordway D, Beckham D, Fornis LB, Majluf-Cruz A, Fugit RV, Freed BM, Kim S, Sandhaus RA, Chan ED. Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19. Sci Rep. 2022 03 25; 12(1):5207.
-
Rocha SM, Fagre AC, Latham AS, Cummings JE, Aboellail TA, Reigan P, Aldaz DA, McDermott CP, Popichak KA, Kading RC, Schountz T, Theise ND, Slayden RA, Tjalkens RB. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection. Front Immunol. 2022; 13:811430.
-
Steiner CA, Berinstein JA, Louissaint J, Higgins PDR, Spence JR, Shannon C, Lu C, Stidham RW, Fletcher JG, Bruining DH, Feagan BG, Jairath V, Baker ME, Bettenworth D, Rieder F. Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2022 04; 20(4):817-846.e10.
-
Ouyang Y, Bagalkot T, Fitzgerald W, Sadovsky E, Chu T, Mart?nez-Marchal A, Brie?o-Enr?quez M, Su EJ, Margolis L, Sorkin A, Sadovsky Y. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin. mSphere. 2021 04 14; 6(2).
-
Wang Z, Rahkola J, Redzic JS, Chi YC, Tran N, Holyoak T, Zheng H, Janoff E, Eisenmesser E. Mechanism and inhibition of Streptococcus pneumoniae IgA1 protease. Nat Commun. 2020 11 27; 11(1):6063.
-
Bai X, Hippensteel J, Leavitt A, Maloney JP, Beckham D, Garcia C, Li Q, Freed BM, Ordway D, Sandhaus RA, Chan ED. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19. Med Hypotheses. 2021 Jan; 146:110394.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|